• To characterize the disease-related glycomics using two complementary approaches: Functional Glycomics and newly developed, high sensitive and high-through-put mass spectrometry.
  • To identify disease related glycomes in blood and urine that represent potentially useful Glycobiomarkers for the early diagnosis, monitoring and treatment of common disease such as cancer, inflammation, life style related-diseases, neurodegenerative diseases, and carbohydrate disorder of glycosylation (CDG)
  • To make a common Database platform
 
 
 
Copyright (C) 2011 HGPI. All Rights Reserved.